The Dolcera Blog

Tweet This Post  Delicious This Post  Digg This Post 

Shall we say the era of complete information disclosure has just begun? and hence the importance of full text patent searching. This blog post is subsequent to our recent post where we cited a classic patent suit where the ‘test of enablement’ was exercised.
Under section US112, the test of enablement requires the claims to be backed by full disclosure of the preferred embodiment in the specification. This tactic has been used by lawyers extensively to invalidate patents in the courts of law.
Hence, as a commercial information service provider the provision of the full text data becomes extremely important to search and analyze since the import of the inventive step may not be fully available from the claims.
In other words, there is potent challenge to perform a thorough patent search given the commercial patent database providers providing just the thumb nail view of the first page. My random informal meetings with Dolcera’s analysts go on to concur on one simple fact that in order to understand the utility of an invention, it is highly advised that a patent search is done on the full specifications of the patent.  They believe that the title, abstract and claims typically make one to understand the novelty and non obviousness while most patents have their utility residing in the full specification.
Further, it is only prudent to have a thorough patent search involving full specifications of the patents where the purpose of patent search is for litigations involving invalidation / infringement and also while searching the prior art. Time and again, it has become a thumb rule for a patent searcher to understand that the patents are often written with a purpose to obscure the patented invention.  We believe that the above reiterates the need to search on the full text and hence the key for future patent searches.
Alternately, the patent dashboard’s new version allows searching the full text of the patent even with simple boolean operators. The search snippets provided beside the pdf documents of patents is where the searched keyword is highlighted on the full text.

Tweet This Post  Delicious This Post  Digg This Post 

The discovery of RNA interference (RNAi) is one of the transforming events in biology. Gene silencing agents such as small interfering RNA (siRNA), micro RNA (miRNA) and small synthetic oligo-nucleotides (DNA, RNA or DNA-RNA complex) lead to target specific RNAi. We aim at building a one-stop comprehensive database of RNAi agents patented or described in scientific literature.Dolcera has provision to customize the database against the target gene suiting client’s requirement. Till now, RNAi agents against some of the important cancer target genes are updated to the database and the trial access is available on request. These genes include bcl2, myc (c-myc, n-myc), ras (k-ras, h-ras, n-ras), VEGF, STAT3 etc. RNAi agents can be extracted and added to the database based on client’s interest.

Dolcera RNAi database can prove helpful:

• For scientific community: RNAi agent sequences aligned to target genes, extensive experimental data and comparison matrix of data from different patents with same focus.  
• For patent attorneys: Competitor watch, assignee vs. number of publications graphs, timeline based on application and publication dates.
• For venture capitalists/ Investors: Patent ranking based on disclosed information, data useful for decision making.

Salient features of the database:

1. Interactive maps of taxonomy: 4 levels of in depth classification of patents and scientific literature allow both “bird’s-eye view” and “in-depth views” of technologies.
2. Patent and non patent dashboard: Grouping specific elements into more general categories is conceptually easier and cleaner than entertaining hundreds of specific elements separately. Dolcera dashboard has a friendly user interface. It groups the patents according to the taxonomy, patent numbers, publications and application dates at the click of a button.
3. Sequence Dashboard: The tool not only aligns all patented/ non patented siRNA/ miRNA sequences to the target gene but allow user to see the sequence related information on a simple click of the mouse.
4. Experimental matrix: Experimental data be it quantitative (eg. % inhibition of target mRNA expression) or qualitative (eg. gel blots) are compared amongst patent document with similar focuses. This allows users to compare literature with same focus. The ranking of documents can also be done based on scoring matrices, which allows user to read the most relevant patent first.

 For database related inquiries or free demo call us at, Phone: +1-650-269-7952 (US) and  +91-40-6451-0832 (India). You can also email us at info@dolcera.com

To read more about RNAi database click here

To visit Dolcera’s website and to explore more patent/ IP related services click here

Tweet This Post  Delicious This Post  Digg This Post